|
53949-53-4
|
1-羥基異丁基苯基-1'-甲基丙酸
|
53949-53-4
|
|
pioglitazone EP impurity D
|
吡格列酮雜質D (EP)
|
868754-41-0
|
|
194935-01-8
|
(3S,5S)-氟伐他汀鈉鹽
|
194935-01-8
|
|
1403474-78-1
|
阿齊沙坦雜質 (I)
|
1403474-78-1
|
|
139481-33-7
|
阿齊沙坦雜質I
|
139481-33-7
|
|
1025064-33-8
|
西那卡塞鹽酸鹽
|
1025064-33-8
|
|
1227626-51-8
|
奧美沙坦酯雜質F
|
1227626-51-8
|
|
157356-74-6
|
奧美沙坦酯雜質V
|
157356-74-6
|
|
1207068-15-2
|
丁酸氯維地平雜質12
|
1207068-15-2
|
|
154377-56-7
|
西那卡塞雜質01
|
154377-56-7
|
|
Oxacillin EP Impurity D
|
苯唑西林鈉EP雜質D
|
1642559-63-4
|
|
53473-36-2
|
3-(4-三氟甲基苯基)丙酸
|
53473-36-2
|
|
olmesartan medoxomil impurity 74
|
厄貝沙坦雜質14
|
133690-91-2
|
|
81886-51-3
|
氟康唑雜質B/(2-(4 氟苯基)-1,3-雙(1H-1,2,4-三唑-1-基)丙烷-2-醇)
|
81886-51-3
|
|
bumetanide impurity 17
|
Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy-
|
28469-01-4
|
|
52250-50-7
|
1-苯基-3,4-二氫異喹啉
|
52250-50-7
|
|
N-Nitroso Propranolol
|
N-亞硝基普萘洛爾
|
84418-35-9
|
|
1813-96-3
|
西那卡塞雜質6
|
1813-96-3
|
|
1499167-72-4
|
阿齊沙坦雜質 (H)
|
1499167-72-4
|
|
1373038-59-5
|
3-[4-[4-(氨基磺?；?苯基]-5-甲基-3-異惡唑基]苯磺酰胺
|
1373038-59-5
|
|
153437-78-6
|
吉非替尼雜質10
|
153437-78-6
|
|
1863930-34-0
|
阿齊沙坦雜質
|
1863930-34-0
|
|
Irbesartan Impurity 16
|
纈沙坦雜質34
|
152708-24-2
|
|
1534326-81-2
|
索利那新雜質 B
|
1534326-81-2
|
|
1340024-54-5
|
布洛芬EP雜質V
|
1340024-54-5
|
|
4-O-Methyldopa Impurity
|
卡比多巴雜質27
|
1269789-01-6
|
|
199327-61-2
|
7-甲氧基-6-(3-嗎啉-4-基丙氧基)喹唑啉-4(3H)-酮
|
199327-61-2
|
|
847949-56-8
|
吉非替尼雜質
|
847949-56-8
|
|
1397836-49-5
|
阿齊沙坦雜質 (C)
|
1397836-49-5
|
|
862207-71-4
|
索非那新琥珀酸相關物質4
|
862207-71-4
|
|
dulaglutide impurity 73
|
達格列凈雜質D
|
2133407-75-5
|
|
1675221-59-6
|
阿齊沙坦雜質
|
1675221-59-6
|
|
94061-80-0
|
(3R,5S)-氟伐他汀鈉鹽
|
94061-80-0
|
|
91854-02-3
|
丁酸氯維地平雜質H152/66
|
91854-02-3
|
|
862207-70-3
|
索非那新琥珀酸相關物質3
|
862207-70-3
|
|
Bromocriptine Impurity
|
BroMocriptine IMpurity F
|
82773-21-5
|
|
36039-35-7
|
布洛芬EP雜質Q
|
36039-35-7
|
|
1048948-15-7
|
奧美沙坦酯雜質G
|
1048948-15-7
|
|
1822601-94-4
|
西那卡塞雜質02
|
1822601-94-4
|
|
1006378-06-8
|
吉非替尼雜質17
|
1006378-06-8
|
|
1824506-44-6
|
西那卡塞雜質03
|
1824506-44-6
|
|
3751-48-2
|
3-(3-甲基苯基)丙酸
|
3751-48-2
|
|
dulaglutide impurity 67
|
Dapagliflozin Impurity 32
|
1528636-07-8
|
|
138564-60-0
|
4-氨基-2-甲基-10H-噻吩[2,3-b][1,5]苯并二氮雜卓鹽酸鹽
|
138564-60-0
|
|
194934-96-8
|
(E)-3,5-二羥基-7-[3'-(4"-氟苯基)-1'-(1"-甲基乙基)吲哚-2'-基]-6-庚烯酸叔丁酯
|
194934-96-8
|
|
65322-85-2
|
布洛芬雜質F
|
65322-85-2
|
|
188649-48-1
|
4-(2',3'-二氯苯基) -2,6-二甲基吡啶-3-羧酸(丁酰氧基甲基)酯-5-羧酸甲酯
|
188649-48-1
|
|
1207963-21-0
|
氟伐他汀EP雜質F
|
1207963-21-0
|
|
1408238-36-7
|
達比加群酯雜質G
|
1408238-36-7
|
|
1353274-25-5
|
索利那新雜質 1
|
1353274-25-5
|
|
514222-44-7
|
氟康唑雜質C
|
514222-44-7
|
|
94061-83-3
|
氟伐他汀IACTONE
|
94061-83-3
|
|
585-50-2
|
3-(3-三氟甲基苯基)丙酸
|
585-50-2
|
|
5,6-trans-Bimatoprost
|
5,6-反式-比馬前列素
|
1163135-95-2
|
|
62833-66-3
|
2-(2-氧代-2,5-二氫-1H-吡咯-1-基)乙酰胺
|
62833-66-3
|
|
1229224-93-4
|
西那卡塞雜質
|
1229224-93-4
|
|
59512-17-3
|
布洛芬雜質C
|
59512-17-3
|
|
94022-99-8
|
3-[2-(三氟甲基)苯基]丙酸
|
94022-99-8
|
|
pioglitazone EP impurity A
|
吡格列酮雜質A (EP)
|
625853-74-9
|
|
60057-62-7
|
布洛芬雜質M
|
60057-62-7
|
|
246512-44-7
|
吉非替尼雜質
|
246512-44-7
|
|
1702936-92-2
|
達比加群酯雜質H
|
1702936-92-2
|
|
1347262-29-6
|
奧美沙坦酯甲基酯
|
1347262-29-6
|
|
935272-10-9
|
奧氮平N乙酰基雜質
|
935272-10-9
|
|
Ampicillin Impurity 19
|
氨芐青霉素EP雜質M
|
114977-84-3
|
|
36039-36-8
|
布洛芬雜質P
|
36039-36-8
|
|
102120-87-6
|
布洛芬雜質R
|
102120-87-6
|
|
64451-76-9
|
布洛芬雜質O
|
64451-76-9
|
|
Flucytosine
|
5-氟胞嘧啶
|
2022-85-7
|
|
N-Nitroso Desmethyl Levofloxacin
|
左氧氟沙星雜質34
|
1152314-62-9
|
|
180468-42-2
|
(S)-1-苯基-1,2,3,4-四氫-2-異喹啉甲酸乙酯
|
180468-42-2
|
|
194934-99-1
|
(3R,5R)-氟伐他汀鈉鹽
|
194934-99-1
|
|
118689-07-9
|
2-(2,4-二氟苯基)-3-(1H-1,2,4-三氮唑-1-基)-1,2-丙二醇
|
118689-07-9
|
|
871550-15-1
|
氟康唑EP雜質B
|
871550-15-1
|
|
605696-10-4
|
索利那新雜質14
|
605696-10-4
|
|
1797982-51-4
|
莫西沙星雜質T
|
1797982-51-4
|
|
Olaparib Impurity 44
|
奧拉帕利雜質40
|
477535-39-0
|
|
161696-76-0
|
N-去甲基奧氮平
|
161696-76-0
|
|
Olodaterol Impurity 18
|
|
2727170-18-3
|
|
110962-94-2
|
氯維地平酯
|
110962-94-2
|
|
761404-85-7
|
三苯甲基奧美沙坦
|
761404-85-7
|
|
1005450-55-4
|
西那卡塞中間體
|
1005450-55-4
|
|
147403-65-4
|
1-[(2'-(羥基脒基)[1,1-聯(lián)苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯
|
147403-65-4
|
|
120428-80-0
|
奧拉西坦進口標準雜質ISF3886
|
120428-80-0
|
|
baricitinib
|
巴瑞克替尼
|
1187594-09-7
|
|
861453-16-9
|
吉非替尼雜質22
|
861453-16-9
|
|
847949-51-3
|
N氧化吉非替尼
|
847949-51-3
|
|
94061-81-1
|
(3S,5R)氟伐他汀鈉鹽
|
94061-81-1
|
|
779-89-5
|
3-三氟甲基肉桂酸
|
779-89-5
|
|
1708094-99-8
|
帕瑞昔布雜質H
|
1708094-99-8
|
|
1348664-75-4
|
氟康唑雜質K
|
1348664-75-4
|
|
1821386-21-3
|
Azilsartan Impurity
|
1821386-21-3
|
|
255706-13-9
|
達比加群乙二酸雜質I
|
255706-13-9
|
|
1391054-15-1
|
反式布洛芬雜質G
|
1391054-15-1
|
|
211915-00-3
|
達比加群雜質J
|
211915-00-3
|
|
1262506-09-1
|
索非那新琥珀酸相關物質2
|
1262506-09-1
|
|
786710-21-2
|
氟伐他汀甲酯
|
786710-21-2
|
|
150194-52-8
|
氟康唑EP雜質H
|
150194-52-8
|
|
150168-54-0
|
氟康唑雜質I
|
150168-54-0
|
|
Olodaterol Impurity 17
|
(S)-Olodaterol
|
868049-50-7
|